Anika Therapeutics CEO Cheryl Blanchard's 2021 pay falls 58% to $4.2M
Anika Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Anika Therapeutics reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, five executives at Anika Therapeutics received on average a compensation package of $1.8M, a 26% decrease compared to previous year.
Average pay of disclosed executives at Anika Therapeutics
Cheryl R. Blanchard, Chief Executive Officer, received $4.2M in total, which decreased by 58% compared to 2020. 35% of Blanchard's compensation, or $1.5M, was in option awards. Blanchard also received $568K in bonus, $668K in salary, $1.5M in stock awards, as well as $23K in other compensation.
Michael L. Levitz, Chief Financial Officer, received a compensation package of $1.6M, which decreased by 14% compared to previous year. 29% of the compensation package, or $456K, was in salary.
David Colleran, General Counsel, earned $1.4M in 2021, a 18% decrease compared to previous year.
Thomas Finnerty, EVP, Human Resources, received $1.1M in 2021, which decreases by 6% compared to 2020.
James Loerop, EVP, Business Development and Strategic Planning, earned $874K in 2021, a 16% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2022.